Sanjit S. Jolly,Marc-André d’Entremont,Shun Fu Lee,Rajibul Mian,Jessica Tyrwhitt,Sasko Kedev,Gilles Montalescot,Jan H. Cornel,Goran Stanković,Raúl Moreno,Robert F. Storey,Timothy D. Henry,Shamir R. Mehta,Matthias Bossard,Petr Kala,Jamie Layland,Biljana Zafirovska,P.J. Devereaux,John W. Eikelboom,John A. Cairns
Among patients who had myocardial infarction, treatment with colchicine, when started soon after myocardial infarction and continued for a median of 3 years, did not reduce the incidence of the composite primary outcome (death from cardiovascular causes, recurrent myocardial infarction, stroke, or unplanned ischemia-driven coronary revascularization). (Funded by the Canadian Institutes of Health Research and others; CLEAR ClinicalTrials.gov number, NCT03048825.).
PDF的下载单位、IP信息已删除
(2025-6-4)
浮游
卡皮巴拉yuan
无极微光
Criminology34
易点邦
香蕉诗蕊
BowieHuang
Twonej
专注的问寒
sswbzh
棋士
彭于彦祖
spc68
罗美女
pluto
stiger
Adc
Maestro_S
轨迹
HOAN
GingerF
cc
乐空思
ShawnJohn
皖公网安备34019202002308
